Children's Mercy Hospital is a 367-bed comprehensive pediatric medical center in Kansas City, Missouri, that integrates clinical care, research and medical education to provide care for patients ages birth to 21. The hospital's primary service area covers a 150-county area in Missouri and Kansas.

During the past decade, Children's Mercy Hospital conducted 388 clinical trials. In the 10-year time frame, 388 clinical trials started and 256 clinical trials were completed, i.e. on average, 66% percent of trials that started reached the finish line to date. In the past 5 years, 158 clinical trials started and 139 clinical trials were completed. i.e. 88% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Children's Mercy Hospital" #1 sponsor was "Children's Oncology Group" with 184 trials, followed by "Children's Mercy Hospital Kansas City" with 161 trials sponsored, "National Cancer Institute (NCI)" with 77 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 22 trials sponsored and "Wake Forest University Health Sciences" with 22 trials sponsored. Other sponsors include 363 different institutions and companies that sponsored additional 193 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Children's Mercy Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 195 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 39 trials as a collaborator, "Children's Mercy Hospital Kansas City" with 27 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 25 trials as a collaborator and "Cystic Fibrosis Foundation" with 17 trials as a collaborator. Other collaborators include 577 different institutions and companies that were collaborators in the rest 315 trials.

According to Clinical.Site data, the most researched conditions in "Children's Mercy Hospital" are "Cystic Fibrosis" (43 trials), "Leukemia" (36 trials), "Neuroblastoma" (35 trials), "Sarcoma" (22 trials) and "Recurrent Neuroblastoma" (21 trials). Many other conditions were trialed in "Children's Mercy Hospital" in a lesser frequency.

Most popular intervention types in "Children's Mercy Hospital" are "Drug" (476 trials), "Other" (195 trials), "Biological" (145 trials), "Procedure" (145 trials) and "Radiation" (82 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (72 trials), "Placebo" (66 trials), "Cyclophosphamide" (51 trials), "cyclophosphamide" (45 trials) and "etoposide" (44 trials). Other intervention names were less common.

The vast majority of trials in "Children's Mercy Hospital" are 798 trials for "All" genders, 18 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are 269 active trials in "Children's Mercy Hospital". 2 are not yet recruiting, 143 are recruiting, 120 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 457 completed trials in Children's Mercy Hospital, 5 suspended trials, and 57 terminated clinical trials to date.

Out of the total trials that were conducted in Children's Mercy Hospital, 87 "Phase 1" clinical trials were conducted, 218 "Phase 2" clinical trials and 226 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 137 trials that are defined as “Not Applicable".

Children's Mercy Hospital has several departments that took part in Clinical trials: "Children's Mercy Hospital and Clinics - Infectious Diseases" - 7 trials, "Children's Mercy on Broadway" - 5 trials, "Children's Mercy Research Institute" - 3 trials, "Children Mercy Pediatric Clinical Research Unit" - 3 trials, "Children's Mercy Hospital- Pediatrics-Site Number:840063" - 2 trials, "TSC Clinic at Children's Mercy Hosptial" - 2 trials, "Mercy Children's Kansas University" - 2 trials